Translating Research Expertise into Clinical iPSC-Derived Cell Therapeutics
- The benefit of robust iPSC reprogramming and differentiation methods to achieve efficient translation from research use to clinical therapeutic applications
- Continuous innovation of an iPSC platform to keep up with the evolving regulatory expectations for iPSC therapeutics
- Evaluation of iPSC line genomics as a benchmark for quality and regulatory risk